Dr Susan Schade-Bijur

1998 - PhD Neuroscience/Pharmacology, University of Alabama at Birmingham, USA

1990 - BS Psychology, University of Kentucky, USA

アメリカ在住。博士号の研究テーマはヒト脳における神経ナトリウムチャネルのプロモーター領域の特定。同研究の成果は、国際神経学会で発表され、査読ャーナルで発表された。クローニング、mRNA、DNAおよびたんぱく質抽出、RT-PCR、ブロッティング、シーケンシング、ならびにゲル電気泳動などの分子生物学分野の手法に精通。脳腫瘍の標的療法に向けた放射性ペプチドに主眼を置くバイオ企業に7年間勤務。研究者兼製造担当シニアマネージャーとして、様々な組織を対象に、ミクロトームを使った組織切片の作製、卵母細胞の抽出、神経膠腫の塩素イオンチャネルの電気生理学的検査などの組織学的実験を実施。また、臨床薬学を担当し、助成金や規制当局への申請書の作成を担当する臨床チームにも参加。同研究を基に、臨床試験に関する論文を含む2報の査読論文を発表。フリーランスのライターとして、医療経済、癌関連の血管新生に関する医学教育分野における執筆活動に加え、50件を超える脂質製剤の 技術告示書を手がける。科学ならびに執筆において非常に広範な経験を有する。
Dr Schade-Bijur’s PhD focused on identifying the promoter region of a neuronal sodium channel in the human brain. Dr Schade-Bijur’s work from these studies has been presented at an international Society of Neuroscience meeting and published in peer-reviewed journals. She is highly skilled in molecular biology techniques, such as cloning, mRNA, DNA and protein extraction, RT-PCR, blotting, sequencing and gel electrophoresis. For seven years Dr Schade-Bijur worked in a biotechnology company that focused on a radioactive peptide as targeted therapy for neuro-oncology. As a scientist and the Senior Manager for Manufacturing, Dr Schade-Bijur performed histology experiments for various tissues, including using a microtome for tissue slice preparation, and oocyte extraction and electrophysiology on a glioma chloride channel. Dr Schade-Bijur was also in charge of the clinical pharmacy and was part of the clinical team writing grants and regulatory documents. From this research she published two more peer-reviewed papers, including a clinical trial paper. As a freelance writer, Dr Schade-Bijur has written in the areas of health economics, medical education regarding cancer angiogenesis and over 50 technical bulletins about lipid products. Dr Schade-Bijur has a particularly broad science and writing background. She joined the Edanz Group as a writer and editor in 2010, specializing in the fields of neuroscience and oncology.